Pep2Tango Therapeutics

BiotechnologySeedPotomac, USpep2tango.com

Latest round

Seed

Last raised

Sep 2024

Total raised

$17M

Investors

1

About Pep2Tango Therapeutics

operates as a biotech research company focused on developing treatments for obesity and related metabolic disorders. In November 2024, Pep2Tango Therapeutics Inc. Pep2Tango Therapeutics developed new peptide drugs that target unmet medical needs, including metabolic, endocrine, CNS, and cardiovascular disorders. Its drug development approach for obesity focuses on unimolecular peptides that target multiple receptors, allowing for weight loss efficacy, muscle mass preservation, improved tolerability, and streamlined development and manufacturability. As of 2024, the firm’s approach focuses on creating unimolecular tetra-receptor agonist peptides that target four key receptors: GLP-1, GIP, amylin, and calcitonin.

Who invested in Pep2Tango Therapeutics

1 investor across 1 round

See all investors in Pep2Tango Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Sep 20, 2024

    Amount

    $17M

    Investors

    Locked

Questions about Pep2Tango Therapeutics

Who invested in Pep2Tango Therapeutics?

Pep2Tango Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Pep2Tango Therapeutics raised?

Pep2Tango Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Pep2Tango Therapeutics last raise money?

Pep2Tango Therapeutics's most recent round on record is a Seed, in Sep 2024.

What does Pep2Tango Therapeutics do?

operates as a biotech research company focused on developing treatments for obesity and related metabolic disorders.

Where is Pep2Tango Therapeutics headquartered?

Pep2Tango Therapeutics is headquartered in Potomac, US.

Which VCs invest in companies like Pep2Tango Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pep2Tango Therapeutics's stage. Their profiles are linked below.

Raising like Pep2Tango Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.